# Monster Beverage Corp: financial statements, quarterly

MNST · Nasdaq · CIK 865752 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mnst.md) · [Financials](/companies/mnst/financials.md) · [Filings](/companies/mnst/filings.md) · [Insiders](/companies/mnst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mnst/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,856](/filings/0001410578-24-001818.md) | [1,730 d](/filings/0001104659-26-020831.md) | [1,899](/filings/0001410578-25-001122.md) | [1,901](/filings/0001410578-25-001620.md) | [1,881](/filings/0001104659-25-107944.md) | [1,812 d](/filings/0001104659-26-020831.md) | [1,855](/filings/0001104659-26-057398.md) | [2,112](/filings/0001104659-26-092193.md) | [2,197](/filings/0001104659-25-107944.md) | [2,131 d](/filings/0001104659-26-020831.md) | [2,353](/filings/0001104659-26-057398.md) | [2,537](/filings/0001104659-26-092193.md) |
| Cost of revenue | $m | [872](/filings/0001410578-24-001818.md) | [792 d](/filings/0001104659-26-020831.md) | [872](/filings/0001410578-25-001122.md) | [881](/filings/0001410578-25-001620.md) | [881](/filings/0001104659-25-107944.md) | [810 d](/filings/0001104659-26-020831.md) | [807](/filings/0001104659-26-057398.md) | [935](/filings/0001104659-26-092193.md) | [973](/filings/0001104659-25-107944.md) | [948 d](/filings/0001104659-26-020831.md) | [1,060](/filings/0001104659-26-057398.md) | [1,118](/filings/0001104659-26-092193.md) |
| Gross profit | $m | [984](/filings/0001410578-24-001818.md) | [938 d](/filings/0001104659-26-020831.md) | [1,027](/filings/0001410578-25-001122.md) | [1,020](/filings/0001410578-25-001620.md) | [1,000](/filings/0001104659-25-107944.md) | [1,002 d](/filings/0001104659-26-020831.md) | [1,048](/filings/0001104659-26-057398.md) | [1,176](/filings/0001104659-26-092193.md) | [1,224](/filings/0001104659-25-107944.md) | [1,183 d](/filings/0001104659-26-020831.md) | [1,293](/filings/0001104659-26-057398.md) | [1,420](/filings/0001104659-26-092193.md) |
| Operating income | $m | [511](/filings/0001410578-24-001818.md) | [434 d](/filings/0001104659-26-020831.md) | [542](/filings/0001410578-25-001122.md) | [527](/filings/0001410578-25-001620.md) | [480](/filings/0001104659-25-107944.md) | [381 d](/filings/0001104659-26-020831.md) | [570](/filings/0001104659-26-057398.md) | [632](/filings/0001104659-26-092193.md) | [675](/filings/0001104659-25-107944.md) | [543 d](/filings/0001104659-26-020831.md) | [730](/filings/0001104659-26-057398.md) | [740](/filings/0001104659-26-092193.md) |
| Income tax | $m | [129](/filings/0001410578-24-001818.md) | [83.1 d](/filings/0001104659-26-020831.md) | [136](/filings/0001410578-25-001122.md) | [126](/filings/0001410578-25-001620.md) | [103](/filings/0001104659-25-107944.md) | [115 d](/filings/0001104659-26-020831.md) | [135](/filings/0001104659-26-057398.md) | [158](/filings/0001104659-26-092193.md) | [165](/filings/0001104659-25-107944.md) | [119 d](/filings/0001104659-26-020831.md) | [181](/filings/0001104659-26-057398.md) | [184](/filings/0001104659-26-092193.md) |
| Net income | $m | [453](/filings/0001410578-24-001818.md) | [367 d](/filings/0001104659-26-020831.md) | [442](/filings/0001104659-25-107944.md) | [425](/filings/0001104659-25-107944.md) | [371](/filings/0001104659-25-107944.md) | [271 d](/filings/0001104659-26-020831.md) | [443](/filings/0001104659-26-092193.md) | [489](/filings/0001104659-26-092193.md) | [524](/filings/0001104659-25-107944.md) | [449 d](/filings/0001104659-26-020831.md) | [569](/filings/0001104659-26-092193.md) | [585](/filings/0001104659-26-092193.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:ProfitLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.8](/filings/0001104659-23-114789.md) | [2.3](/filings/0001410578-25-000248.md) | [2.6](/filings/0001410578-24-000605.md) | [1.6](/filings/0001410578-24-001239.md) | [1.6](/filings/0001410578-24-001818.md) | [1.5](/filings/0001104659-26-020831.md) | [1.9](/filings/0001410578-25-001122.md) | [1.9](/filings/0001410578-25-001620.md) | [2.3](/filings/0001104659-25-107944.md) | [2.1](/filings/0001104659-26-092193.md) | [2.0](/filings/0001104659-26-057398.md) | [2.2](/filings/0001104659-26-092193.md) |
| Current assets | $bn | [5.3](/filings/0001104659-23-114789.md) | [5.6](/filings/0001410578-25-000248.md) | [6.0](/filings/0001410578-24-000605.md) | [4.0](/filings/0001410578-24-001239.md) | [3.9](/filings/0001410578-24-001818.md) | [3.6](/filings/0001104659-26-020831.md) | [4.1](/filings/0001410578-25-001122.md) | [4.4](/filings/0001410578-25-001620.md) | [5.1](/filings/0001104659-25-107944.md) | [5.4](/filings/0001104659-26-092193.md) | [5.9](/filings/0001104659-26-057398.md) | [6.4](/filings/0001104659-26-092193.md) |
| Total assets | $bn | [9.3](/filings/0001104659-23-114789.md) | [9.7](/filings/0001410578-25-000248.md) | [10.1](/filings/0001410578-24-000605.md) | [8.1](/filings/0001410578-24-001239.md) | [8.1](/filings/0001410578-24-001818.md) | [7.7](/filings/0001104659-26-020831.md) | [8.2](/filings/0001410578-25-001122.md) | [8.7](/filings/0001410578-25-001620.md) | [9.6](/filings/0001104659-25-107944.md) | [10.0](/filings/0001104659-26-092193.md) | [10.8](/filings/0001104659-26-057398.md) | [11.4](/filings/0001104659-26-092193.md) |
| Current liabilities | $bn | [1.2](/filings/0001104659-23-114789.md) | [1.2](/filings/0001410578-25-000248.md) | [1.2](/filings/0001410578-24-000605.md) | [1.2](/filings/0001410578-24-001239.md) | [1.2](/filings/0001410578-24-001818.md) | [1.1](/filings/0001104659-26-020831.md) | [1.2](/filings/0001410578-25-001122.md) | [1.3](/filings/0001410578-25-001620.md) | [1.6](/filings/0001104659-25-107944.md) | [1.4](/filings/0001104659-26-092193.md) | [1.8](/filings/0001104659-26-057398.md) | [1.7](/filings/0001104659-26-092193.md) |
| Long-term debt | $bn | not reported | [0.0](/filings/0001410578-24-001818.md) | not reported | [0.7](/filings/0001410578-24-001239.md) | [0.7](/filings/0001410578-24-001818.md) | [0.4](/filings/0001104659-26-020831.md) | [0.2](/filings/0001410578-25-001122.md) | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | [0.0](/filings/0001410578-24-001818.md) | not reported | not reported | [0.0](/filings/0001410578-24-001818.md) | [0.0](/filings/0001104659-25-107944.md) | [0.0](/filings/0001410578-25-001122.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [7.9](/filings/0001410578-24-001818.md) | [8.2](/filings/0001104659-26-020831.md) | [8.6](/filings/0001104659-25-107944.md) | [5.9](/filings/0001104659-25-107944.md) | [5.8](/filings/0001104659-25-107944.md) | [6.0](/filings/0001104659-26-092193.md) | [6.5](/filings/0001104659-26-092193.md) | [7.2](/filings/0001104659-26-092193.md) | [7.7](/filings/0001104659-25-107944.md) | [8.3](/filings/0001104659-26-092193.md) | [8.7](/filings/0001104659-26-092193.md) | [9.4](/filings/0001104659-26-092193.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [520 d](/filings/0001410578-24-001818.md) | [434 d](/filings/0001104659-26-020831.md) | [412](/filings/0001410578-25-001122.md) | [436 d](/filings/0001410578-25-001620.md) | [618 d](/filings/0001104659-25-107944.md) | [462 d](/filings/0001104659-26-020831.md) | [508](/filings/0001104659-26-057398.md) | [466 d](/filings/0001104659-26-092193.md) | [745 d](/filings/0001104659-25-107944.md) | [379 d](/filings/0001104659-26-020831.md) | [605](/filings/0001104659-26-057398.md) | [509 d](/filings/0001104659-26-092193.md) |
| Capital expenditure | $m | [27.8 d](/filings/0001410578-24-001818.md) | [111 d](/filings/0001104659-26-020831.md) | [66.0](/filings/0001410578-25-001122.md) | [59.8 d](/filings/0001410578-25-001620.md) | [47.0 d](/filings/0001104659-25-107944.md) | [91.3 d](/filings/0001104659-26-020831.md) | [29.1](/filings/0001104659-26-057398.md) | [31.4 d](/filings/0001104659-26-092193.md) | [43.6 d](/filings/0001104659-25-107944.md) | [28.2 d](/filings/0001104659-26-020831.md) | [20.6](/filings/0001104659-26-057398.md) | [48.4 d](/filings/0001104659-26-092193.md) |
| Share repurchases | $m | [397 d](/filings/0001410578-24-001818.md) | [171 d](/filings/0001104659-26-020831.md) | [120](/filings/0001410578-25-001122.md) | [3,114 d](/filings/0001410578-25-001620.md) | [536 d](/filings/0001104659-25-107944.md) | [1.7 d](/filings/0001104659-26-020831.md) | [16.6](/filings/0001104659-26-057398.md) | [0.0 d](/filings/0001104659-26-092193.md) | [27.3 d](/filings/0001104659-25-107944.md) | [59.7 d](/filings/0001104659-26-020831.md) | [134](/filings/0001104659-26-057398.md) | [0.0 d](/filings/0001104659-26-092193.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,067](/filings/0001104659-23-114789.md) | [1,059](/filings/0001410578-24-000605.md) | [1,060](/filings/0001410578-24-001239.md) | [1,060](/filings/0001410578-24-001818.md) | [1,051](/filings/0001410578-25-001122.md) | [1,037](/filings/0001410578-25-001620.md) | [983](/filings/0001104659-25-107944.md) | [981](/filings/0001104659-26-057398.md) | [984](/filings/0001104659-26-092193.md) | [985](/filings/0001104659-25-107944.md) | [988](/filings/0001104659-26-057398.md) | [988](/filings/0001104659-26-092193.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 979,525,882 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092193.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.